Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Astrana Health Affirms FY2025 Sales Guidance of $3.100B-$3.300B vs $2.763B Est

Author: Benzinga Newsdesk | August 07, 2025 03:13pm
Astrana Health (NASDAQ:ASTH) affirms FY2025 sales outlook from $3.100 billion-$3.300 billion to $3.100 billion-$3.300 billion vs $2.763 billion estimate.

Posted In: ASTH


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist